GuruTrack
ABT

ABT

ABBOTT LABORATORIES

Data as of 2026 Q1 (03-31) · 13F snapshot

Summary
ABBOTT LABORATORIES (ABT) is held by 9 tracked hedge-fund managers, a combined reported value of ~$1.13B; the largest are Ken Griffin, Bill Gates, Ken Griffin. This quarter: 1 new, 3 added, 2 trimmed. 20 members of Congress have disclosed STOCK Act trades. Data as of 2026 Q1, from public SEC 13F filings, delayed up to ~45 days.
Attention · HighThis quarter · Heating up
Gurus holding9
Congress trades20
Price$103.06vs quarter-end+0.38%
Sectors1
This quarter's moves
New1
Added3
Trimmed / sold2
Top holderKen Griffin
Value $161.38M— of portfolio1,571,8002026 Q1
Dan LoebNew large stake
Value $124.57M2.4% of portfolio3,250,0002013 Q4
Value $47.08M— of portfolio458,6002026 Q1
Value $34.15M— of portfolio332,6002026 Q1
Value $24.82M— of portfolio241,7002026 Q1
Value $10.78M— of portfolio105,0002026 Q1
Value $6.48M— of portfolio63,1002026 Q1

Insider Trading

Officers · directors · Form 4
  • Louis H. Morrone

    EXECUTIVE VICE PRESIDENT

    Sell$24.9K
    269 @ $92.71Traded 2026-06-30Filed 2026-07-01
  • Patricia Paola Gonzalez

    Director

    Buy$32.9K
    363Traded 2026-06-30Filed 2026-07-01
  • Michael F Roman

    Director

    Buy$37.7K
    416Traded 2026-06-30Filed 2026-07-01
  • John G Stratton

    Director

    Buy$39.2K
    432Traded 2026-06-30Filed 2026-07-01
  • Nita Ahuja

    Director

    Buy$31.5K
    347Traded 2026-06-30Filed 2026-07-01
  • Kevin T Conroy

    Director

    Buy$21.0K
    231Traded 2026-06-30Filed 2026-07-01
  • Elizabeth C. Cushman

    EVP, GC AND SECRETARY

    Sell$52.7K
    560 @ $94.12Traded 2026-06-27Filed 2026-06-29
  • John G Stratton

    Director

    Buy$173.6K
    2,000 @ $86.82Traded 2026-05-07Filed 2026-06-18
  • Mary K Moreland

    EXECUTIVE VICE PRESIDENT

    Buy$501.7K
    5,314 @ $94.41Traded 2026-04-28Filed 2026-04-29
  • Michael F Roman

    Director

    Buy
    2,286 @ $0.00Traded 2026-04-24Filed 2026-04-28
  • Michelle Kumbier

    Director

    Buy
    2,286 @ $0.00Traded 2026-04-24Filed 2026-04-28
  • Darren W Mcdew

    Director

    Buy
    2,286 @ $0.00Traded 2026-04-24Filed 2026-04-28
  • Patricia Paola Gonzalez

    Director

    Buy
    2,286 @ $0.00Traded 2026-04-24Filed 2026-04-28
  • Sally E. Blount

    Director

    Buy
    2,286 @ $0.00Traded 2026-04-24Filed 2026-04-28
  • Daniel J Starks

    Director

    Buy
    7,105 @ $91.86Traded 2026-04-24Filed 2026-04-28
  • John G Stratton

    Director

    Buy
    2,286 @ $0.00Traded 2026-04-24Filed 2026-04-28
  • Nancy Mckinstry

    Director

    Buy
    2,305 @ $91.86Traded 2026-04-24Filed 2026-04-28
  • Daniel J Starks

    Director

    Buy
    2,286 @ $0.00Traded 2026-04-24Filed 2026-04-28
  • Nancy Mckinstry

    Director

    Buy
    2,286 @ $0.00Traded 2026-04-24Filed 2026-04-28
  • Michael O'Grady

    Director

    Buy
    2,286 @ $0.00Traded 2026-04-24Filed 2026-04-28
  • Michael O'Grady

    Director

    Buy
    5,929 @ $91.86Traded 2026-04-24Filed 2026-04-28
  • Daniel J Starks

    Director

    Buy$926.5K
    10,000 @ $92.65Traded 2026-04-24Filed 2026-04-28
  • Nita Ahuja

    Director

    Buy
    2,286 @ $0.00Traded 2026-04-24Filed 2026-04-28
  • Claire Babineaux-Fontenot

    Director

    Buy
    2,286 @ $0.00Traded 2026-04-24Filed 2026-04-28

Insider transactions are public SEC Form 4 disclosures (company officers, directors, 10% owners), for research only — not investment advice.

Data from public SEC 13F & STOCK Act filings, delayed up to ~45 days, partial holdings only — for research, not investment advice.